myoview markierungsbesteck
ge healthcare ag - tetrofosminum - markierungsbesteck - praeparatio cryodesiccata: tetrofosminum 0.23 mg, stannosi chloridum dihydricum, dinatrii sulfosalicylas, natrii gluconas, natrii hydrogenocarbonas, pro vitro corresp. natrium 0.65 mg. - szintigraphische Étude de la myokarddurchblutung - radiopharmazeutika
visipaque 270 solution
ge healthcare canada inc - iodixanol - solution - 550mg - iodixanol 550mg - roentgenography
visipaque 320 solution
ge healthcare canada inc - iodixanol - solution - 652mg - iodixanol 652mg - roentgenography
omnipaque 180 solution
ge healthcare canada inc - iohexol - solution - 388mg - iohexol 388mg - roentgenography
omnipaque 240 solution
ge healthcare canada inc - iohexol - solution - 518mg - iohexol 518mg - roentgenography
omnipaque 300 solution
ge healthcare canada inc - iohexol - solution - 647mg - iohexol 647mg - roentgenography
omnipaque 350 solution
ge healthcare canada inc - iohexol - solution - 755mg - iohexol 755mg - roentgenography
omniscan solution
ge healthcare canada inc - gadodiamide - solution - 287mg - gadodiamide 287mg - other diagnostic agents
ceretec poudre pour solution
ge healthcare canada inc - examétazime - poudre pour solution - 0.5mg - examétazime 0.5mg - roentgenography
ivepaque 350 mg i/ml, solution injectable
ge healthcare sas - iode - solution - 35,0 g - composition pour 100 ml de solution > iode : 35,0 g . sous forme de : iopentol 76,8 g - produit de contraste iode